[go: up one dir, main page]

NO864872L - Paavisning av aktiverte blodplater med antistoffer mot celleoverflateantigener. - Google Patents

Paavisning av aktiverte blodplater med antistoffer mot celleoverflateantigener.

Info

Publication number
NO864872L
NO864872L NO864872A NO864872A NO864872L NO 864872 L NO864872 L NO 864872L NO 864872 A NO864872 A NO 864872A NO 864872 A NO864872 A NO 864872A NO 864872 L NO864872 L NO 864872L
Authority
NO
Norway
Prior art keywords
receptor
stimulated
platelet
antigen
detection
Prior art date
Application number
NO864872A
Other languages
English (en)
Other versions
NO170128B (no
NO170128C (no
NO864872D0 (no
Inventor
Mark H Ginsberg
Edward F Plow
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO864872L publication Critical patent/NO864872L/no
Publication of NO864872D0 publication Critical patent/NO864872D0/no
Publication of NO170128B publication Critical patent/NO170128B/no
Publication of NO170128C publication Critical patent/NO170128C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/806—Electrical property or magnetic property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO864872A 1985-04-04 1986-12-04 Fremgangsmaate for dannelse av et monoklonalt antistoff for anvendelse som et diagnostisk posisjonsspesifikt reagens NO170128C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/720,032 US4820505A (en) 1985-04-04 1985-04-04 Detection of activated platelets with antibodies to thrombospondin
PCT/US1986/000616 WO1986005693A1 (en) 1985-04-04 1986-03-25 Detection of activated platelets with antibodies to cell surface antigens

Publications (4)

Publication Number Publication Date
NO864872L true NO864872L (no) 1986-12-04
NO864872D0 NO864872D0 (no) 1986-12-04
NO170128B NO170128B (no) 1992-06-09
NO170128C NO170128C (no) 1992-09-16

Family

ID=24892375

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864872A NO170128C (no) 1985-04-04 1986-12-04 Fremgangsmaate for dannelse av et monoklonalt antistoff for anvendelse som et diagnostisk posisjonsspesifikt reagens

Country Status (10)

Country Link
US (1) US4820505A (no)
EP (1) EP0216864B1 (no)
JP (1) JP2752614B2 (no)
AT (1) ATE76301T1 (no)
CA (1) CA1264029A (no)
DE (1) DE3685390D1 (no)
DK (1) DK173787B1 (no)
ES (1) ES8801439A1 (no)
NO (1) NO170128C (no)
WO (1) WO1986005693A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225181A (en) * 1985-06-07 1993-07-06 The Research Foundation Of State University Of New York Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi
FI884721A7 (fi) * 1987-10-15 1989-04-16 Moskovsky Gosudarstvenny Univ Fluorijohdannnaisten käyttö varjoaineina
US5372933A (en) * 1988-10-03 1994-12-13 The Scripps Research Institute Polypeptides that mimic receptor-induced binding sites, and methods of using same
US5024829A (en) * 1988-11-21 1991-06-18 Centocor, Inc. Method of imaging coronary thrombi
US5026537A (en) * 1989-04-06 1991-06-25 Centocor, Inc. Methods for imaging atherosclerotic plaque
US5185142A (en) * 1989-07-28 1993-02-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapy
US5116599A (en) * 1989-07-31 1992-05-26 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri
AU6964891A (en) * 1989-11-03 1991-05-31 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Novel monoclonal antibody against human platelets
EP0806670B1 (de) * 1989-12-27 2009-04-22 Boehringer Ingelheim International GmbH Verwendung eines Antikoagulant als Diagnostikum
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5192744A (en) * 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5196309A (en) * 1990-11-15 1993-03-23 The Scripps Research Institute Characterization of platelet aggregation disorders
DK0559795T3 (da) * 1990-11-30 1996-01-29 Monoclonetics Int Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
US5256538A (en) * 1991-03-08 1993-10-26 Board Of Regents, The University Of Texas System Detection of early platelet activation and prediagnosis of thrombotic events
US5807745A (en) * 1991-03-11 1998-09-15 New England Medical Center Hospitals, Inc. Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
SE469451B (sv) * 1991-06-28 1993-07-05 Anders Larsson Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar
EP0673391A4 (en) * 1991-10-01 1995-11-22 Gen Hospital Corp PROTEIN DEPENDING ON ACTIVATION AND EXPRESSED ON THE SURFACE OF ACTIVE PLATES AND RELATED ANTIBODIES.
US5457028A (en) * 1992-04-22 1995-10-10 Milwaukee Heart Research Foundation Standard platelet samples and method for preparation thereof
WO1994016743A1 (en) 1993-01-26 1994-08-04 Allergan, Inc. Compositions and methods to disinfect contact lenses
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US20030220233A1 (en) * 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7029468B2 (en) * 2002-06-25 2006-04-18 Enpath Medical, Inc. Catheter assembly with side wall exit lumen and method therefor
US7655411B2 (en) * 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
WO2016014939A1 (en) 2014-07-24 2016-01-28 Washington University Compositions targeting radiation-induced molecules and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3789116A (en) * 1970-12-09 1974-01-29 Abbott Lab Fluorescent labeled antibody reagent
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
JPS6058927A (ja) * 1983-09-09 1985-04-05 Nippon Mejifuijitsukusu Kk 放射能標識血小板製剤
US4610960A (en) * 1983-12-21 1986-09-09 Wisconsin Alumni Research Foundation Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets

Also Published As

Publication number Publication date
EP0216864A1 (en) 1987-04-08
NO170128B (no) 1992-06-09
ES8801439A1 (es) 1987-12-16
EP0216864B1 (en) 1992-05-20
DE3685390D1 (de) 1992-06-25
US4820505A (en) 1989-04-11
JP2752614B2 (ja) 1998-05-18
NO170128C (no) 1992-09-16
ES553738A0 (es) 1987-12-16
EP0216864A4 (en) 1989-09-26
JPS62502964A (ja) 1987-11-26
DK173787B1 (da) 2001-10-22
WO1986005693A1 (en) 1986-10-09
ATE76301T1 (de) 1992-06-15
CA1264029A (en) 1989-12-27
DK581386D0 (da) 1986-12-03
NO864872D0 (no) 1986-12-04
DK581386A (da) 1986-12-03

Similar Documents

Publication Publication Date Title
NO864872D0 (no) Paavisning av aktiverte blodplater med antistoffer mot celleoverflateantigener.
Ashcroft et al. 5-Hydroxyindoles in human cerebrospinal fluids
JPS63501172A (ja) 特異的結合アッセイにおける成分の分離，混合および検出のための方法および装置
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
DE3854496D1 (de) Peptide und antikörper, die die bindung von blutplättchen verhindern.
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
ATE123340T1 (de) Diagnostischer nachweis unter verwendung von chimären antikörpern.
DE3883073D1 (de) Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel.
Springer et al. Cell adhesion molecules: detection with univalent second antibody.
GR3005971T3 (no)
DK199783A (da) Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer
ATE102357T1 (de) Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz.
Devey et al. Measurement of antigen-antibody complexes in mouse sera by conglutinin, C1q and rheumatoid factor solid phase binding assays
ATE188551T1 (de) Feststellung von antikörperproduktion
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
DK414386A (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
SARVAS et al. ANTI‐DNA ANTIBODIES: THE CHOICE OF ASSAYS FOR ROUTINE DIAGNOSTIC WORK
ATE184286T1 (de) Hgpiib-fragmente und ihre verwendung in in-vitro- verfahren zur bestimmung von in vivo stattfindenden thrombotischen ereignissen
Maidment Jr et al. Isoelectric focusing analysis of soluble immune complexes bound to Protein A-Sepharose
Hopkins et al. Latex agglutination test for detection of Australia antigen (HB-Ag) among blood donors and patients
ATE120009T1 (de) Verfahren zur quantitativen bestimmung von serumproteinen in körperflüssigkeiten und mittel zur durchführung des verfahrens.
AU8008487A (en) A method for determining the presence of substances of diagnostic relevance, in particular antibodies or antigens, by the ELISA method with photometric evaluation
DE3863270D1 (de) Immuntest.
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns
TH3949A (th) วิธีการตรวจหาโดยอัตโนมัติสำหรับปฏิกิริยาที่เกิดการเกาะเป็นกลุ่ม และเครื่องอุปกรณ์สำหรับวิธีการดังกล่าว